feed,title,long_url,short_url
SeekingAlpha,Bristol's up to $3B deal with Eisai puts antibody drug conjugates in the spotlight,https://seekingalpha.com/news/3707699,
SeekingAlpha,UiPath: Comprehensive Breakdown Of The Leading Robotic Process Automation Player,https://seekingalpha.com/article/4435505,
